A Systematic Review on the Safety and Efficacy of PCSK9 Inhibitors in Lowering Cardiovascular Risks in Patients With Chronic Kidney Disease.
Cureus
; 14(9): e29140, 2022 Sep.
Article
en En
| MEDLINE
| ID: mdl-36128564
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Systematic_reviews
Idioma:
En
Año:
2022
Tipo del documento:
Article